Insider · CIK 0002059152
Andrew John Oakley
Files at ONCO (Onconetix, Inc.). First filing -, latest -.
In brief
Andrew John Oakley files SEC Form 4 as director at ONCO (Onconetix, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Andrew John Oakley has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 15, 2025 | ONCO Onconetix, Inc. | JOther Common Stock | +20 | $0.00 | $0 | 20 | Aug 19, 2025 |
| Aug 15, 2025 | ONCO Onconetix, Inc. | AGrant or award Common Stock | +618 | $0.00 | $0 | 638 | Aug 19, 2025 |
Questions about Andrew John Oakley
Answered from the filings on this page, as of the latest one.
Is Andrew John Oakley buying or selling?
Andrew John Oakley has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Andrew John Oakley's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Andrew John Oakley has 0.
Where does Andrew John Oakley file Form 4?
Andrew John Oakley has filed Form 4 at ONCO (Onconetix, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.